NF-κB in photodynamic therapy: Discrepancies of a master regulator

Photochemistry and Photobiology

Volumn 82, Issue 5, 2006, Pages 1241-1246

  Matroule, Jean Yves ^a   Volanti, Cedric ^a   Piette, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

BIOLOGICAL MODEL; HUMAN; NEOPLASM; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NF-KAPPA B; OXIDATIVE STRESS; PHOTOCHEMOTHERAPY; SIGNAL TRANSDUCTION;

EID: 33750694955     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2006-03-30-IR-862     Document Type: Conference Paper

References (39)

1. Cadet, J., M. Berger, C. Decarroz, J. R. Wagner, J. E. van Lier, Y. M. Ginot and P. Vigny (1986) Photosensitized reactions of nucleic acids. Biochimie 68, 813-834.
2. Grossweiner, L. I. (1984) Photochemistry of proteins: A review. Curr. Eye Res. 3, 137-144.
3. Santus, R. and J. P. Reyftmann (1986) Photosensitization of membrane components. Biochimie 68, 843-848.
4. Cecic, I. and M. Korbelik (2002) Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183, 43-51.
5. Sun, J., I. Cecic, C. S. Parkins and M. Korbelik (2002) Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours. Photochem. Photobiol. Sci. 1, 690-695.
6. Gollnick, S. O., S. S. Evans, H. Baumann, B. Owczarczak, P. Maier, L. Vaughan, W. C. Wang, E. Unger and B. W. Henderson (2003) Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88, 1772-1779.
7. Mercurio, F. and A. M. Manning (1999) Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol. 11, 226-232.
8. Ghosh, S. and M. Karin (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl.), S81-96.
9. Hayden, M. S. and S. Ghosh (2004) Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
10. Bonizzi, G. and M. Karin (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
11. Amir, R. E., H. Haecker, M. Karin and A. Ciechanover (2004) Mechanism of processing of the NF-kappa B2 p100 precursor: Identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase. Oncogene 23, 2540-2547.
12. Schreck, R., P. Rieber and P. A. Baeuerle (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 2247-2258.
13. Schoonbroodt, S. and J. Piette (2000) Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem. Pharmacol. 60, 1075-1083.
14. Gloire, G., S. Legrand-Poels and J. Piette (2006) NF-kB activation by reactive oxygen species: Fifteen years later. Biochem. Pharmacol. (In press, DOI: 10.1016/j.bcp.2006.04.011)
15. Ryter, S. W. and C. J. Gomer (1993) Nuclear factor kappa B binding activity in mouse L1210 cells following Photofrin II-mediated photosensitization. Photochem. Photobiol. 58, 753-756.
16. Kick, G., G. Messer, A. Goetz, G. Plewig and P. Kind (1995) Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res. 55, 2373-2379.
17. Piret, B., S. Legrand-Poels, C. Sappey and J. Piette (1995) NF-kappa B transcription factor and human immunodeficiency virus type 1 (HIV-1) activation by methylene blue photosensitization. Eur. J. Biochem. 228, 447-455.
18. Legrand-Poels, S., V. Bours, B. Piret, M. Pflaum, B. Epe, B. Rentier and J. Piette (1995) Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damages. J. Biol. Chem. 270, 6925-6934.
19. Matroule, J. Y., G. Bonizzi, P. Morliere, N. Paillous, R. Santus, V. Bours and J. Piette (1999) Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. J. Biol. Chem. 274, 2988-3000.
20. Ryter, S. W. and R. M. Tyrrell (1998) Singlet molecular oxygen ((1)O2): A possible effector of eukaryotic gene expression. Free Radic. Biol. Med. 24, 1520-1534.
21. Krutmann, J., M. Athar, D. B. Mendel, I. U. Khan, P. M. Guyre, H. Mukhtar and C. A. Elmets (1989) Inhibition of the high affinity Fc receptor (Fc gamma RI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals. J. Biol. Chem. 264, 11407-11413.
22. Glinski, J. A., E. David, T. C. Warren, G. Hansen, S. F. Leonard, P. Pitner, S. Pav, R. Arvigo, M. J. Balick, and E. Panta et al. (1995) Inactivation of cell surface receptors by pheophorbide a, a green pigment isolated from Psychotria acuminata. Photochem. Photobiol. 62, 144-150.
23. Volanti, C., J. Y. Matroule and J. Piette (2002) Involvement of oxidative stress in NF-kappaB activation in endothelial cells treated by photodynamic therapy. Photochem. Photobiol. 75, 36-45.
24. Fingar, V. H. (1996) Vascular effects of photodynamic therapy. J. Clin. Laser Med. Surg. 14, 323-328.
25. Volanti, C., G. Gloire, A. Vanderplasschen, N. Jacobs, Y. Habraken and J. Piette (2004) Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy. Oncogene 23, 8649-8658.
26. Shishodia, S. and B. B. Aggarwal (2002) Nuclear factor-kappaB activation: A question of life or death. J. Biochem. Mol. Biol. 35, 28-40.
27. Lin, B., C. Williams-Skipp, Y. Tao, M. S. Schleicher, L. L. Cano, R. C. Duke and R. I. Scheinman (1999) NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 6, 570-582.
28. Karin, M. and A. Lin (2002) NF-kappaB at the crossroads of life and death. Nat. Immun. 3, 221-227.
29. Matroule, J. Y., C. M. Carthy, D. J. Granville, O. Jolois, D. W. Hunt and J. Piette (2001) Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide - A methylester photosensitization. Oncogene 20, 4070-4084.
30. Matroule, J. Y., A. C. Hellin, P. Morliere, A. S. Fabiano, R. Santus, M. P. Merville and J. Piette (1999) Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization. Photochem. Photobiol. 70, 540-548.
31. Williams, C. S., M. Mann and R. N. DuBois (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908-7916.
32. Ferrario, A., A. M. Fisher, N. Rucker and C. J. Gomer (2005) Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res. 65, 9473-9478.
33. Zhou, Q., M. Olivo, K. Y. Lye, S. Moore, A. Sharma and B. Chowbay (2005) Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother. Pharmacol. 56, 569-577.
34. Yee, K. K., K. C. Soo and M. Olivo (2005) Anti-angiogenic effects of hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. Int. J. Mol. Med. 16, 993-1002.
35. Volanti, C., N. Hendrickx, J. Van Lint, J. Y. Matroule, P. Agostinis and J. Piette (2005) Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24, 2981-2991.
36. Hendrickx, N., C. Volanti, U. Moens, O. M. Seternes, P. de Witte, J. R. Vandenheede, J. Piette and P. Agostinis (2003) Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem. 278, 52231-52239.
37. Overall, C. M. and C. Lopez-Otin (2002) Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672.
38. Karrer, S., A. K. Bosserhoff, P. Weiderer, M. Landthaler and R. M. Szeimies (2004) Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br. J. Dermatol. 151, 776-783.
39. Ferrario, A., C. F. Chantrain, K. von Tiehl, S. Buckley, N. Rucker, D. R. Shalinsky, H. Shimada, Y. A. DeClerck and C. J. Gomer (2004) The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model. Cancer Res. 64, 2328-2332.